3,126
Views
24
CrossRef citations to date
0
Altmetric
Autophagic Punctum

Aspirin—another caloric-restriction mimetic

, , & ORCID Icon
Pages 1162-1163 | Received 02 Mar 2018, Accepted 16 Mar 2018, Published online: 18 Jul 2018

Figures & data

Figure 1. Comparison of aspirin with other caloric-restriction mimetics. (A). Caloric-restriction mimetics may directly inhibit acetyltransferases, deplete acetyl coenzyme A (AcCoA) or activate deacetylases to stimulate protein deacetylation and consequent autophagy induction. (B) Salicylate generated from its prodrug, aspirin, directly inhibits the acetyltransferase activity of EP300, thus acting as a class I caloric-restriction mimetic to induce protein deacetylation and autophagy.

Figure 1. Comparison of aspirin with other caloric-restriction mimetics. (A). Caloric-restriction mimetics may directly inhibit acetyltransferases, deplete acetyl coenzyme A (AcCoA) or activate deacetylases to stimulate protein deacetylation and consequent autophagy induction. (B) Salicylate generated from its prodrug, aspirin, directly inhibits the acetyltransferase activity of EP300, thus acting as a class I caloric-restriction mimetic to induce protein deacetylation and autophagy.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.